Novel treatment modality in a case of resistant erythromelalgia

Authors

  • Vidya D. Kharkar Department of Dermatology, King Edward Memorial Hospital and Seth GS Medical College, Mumbai, Maharashtra, India
  • Agni K. Bose Department of Dermatology, King Edward Memorial Hospital and Seth GS Medical College, Mumbai, Maharashtra, India
  • Pandharinath K. Khade Department of Dermatology, King Edward Memorial Hospital and Seth GS Medical College, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20203758

Keywords:

Erythromelalgia, Pentoxifylline, Sympathectomy, Resistant

Abstract

Erythromelalgia presents with redness, pain and warmth of the extremities, which is exacerbated by warming and relieved by cooling. Treatment of pain in erythromelalgia can be difficult, and often polypharmacy is utilized. No single therapy has been found to provide complete relief for any patient. Therefore, a multidisciplinary approach is required to treat pain and its significant negative impact across many domains of functioning. A 21 year old male diagnosed case of primary erythromelalgia since 5 years, presented multiple times with recurrent pain and erythema in bilateral lower limbs. Patient was treated initially with oral antibiotics, tramadol and prednisolone, without relief. Aspirin, amitriptyline, pregabalin, carbamazepine, atenolol were later added which gave him partial relief. Epidural caudal catheter with daily infusion of anesthesia was added along with topical buprenorphine patch when conservative polypharmacy failed to provide complete relief and later unilateral lumbar sympathectomy was done as a last resort. Adding pentoxifylline and compression therapy improved the patient’s condition drastically and complete remission is in progress. The patient required a multidisciplinary approach for pain management and surgical intervention was required due to his refractory nature. However, this also does not give complete relief and thus a combination of both medical and surgical methods is required for best control of symptoms.

Metrics

Metrics Loading ...

Author Biographies

Vidya D. Kharkar, Department of Dermatology, King Edward Memorial Hospital and Seth GS Medical College, Mumbai, Maharashtra, India

Professor and Head of Department, Department of Dermatology, Venereology and Leprology

Agni K. Bose, Department of Dermatology, King Edward Memorial Hospital and Seth GS Medical College, Mumbai, Maharashtra, India

Resident Doctor. Department of Dermatology,Venereology and Leprology

Pandharinath K. Khade, Department of Dermatology, King Edward Memorial Hospital and Seth GS Medical College, Mumbai, Maharashtra, India

Resident Doctor. Department of Dermatology, Venereology and Leprology

References

Gregory C, Zhonghui G. Case Report and Literature Review: Interventional Management of Erythromelalgia. Transl Perioper Pain Med. 2019;6(4):91-7.

Drenth JPH, Te Morsche RHM, Guillet G, Taieb A, Kirby RL, Jansen JBMJ. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol. 2005;124(6):1333-8.

Buttaci CJ. Erythromelalgia: A case report and literature review. Pain Med. 2006;7(6):534-8.

de Albuquerque LGM, de França ER, Kozmhinsky V, Querino MCD, de Morais AG. Eritromelalgia primária-Relato de caso. An Bras Dermatol. 2011;86(1):131-4.

Mann N, King T, Murphy R. Review of primary and secondary erythromelalgia. Clin Exp Dermatol. 2019;44(5):477-82.

Cohen JS. Erythromelalgia: New theories and new therapies. J Am Acad Dermatol. 2000;43(5):841-7.

Gaur S, Koroscil T. Late-onset erythromelalgia in a previously healthy young woman: A case report and review of the literature. J Med Case Rep. 2009;3.

Downloads

Published

2020-08-26